Skip to main content
. 2020 Apr 21;2(5):261–268. doi: 10.1002/acr2.11133

Table 2.

Projected increases in operational capacity

  No. of Infusions Hours of Infusions
Overall First Tx Second Tx Overall First Tx Second Tx
Baseline infusion capacity            
per d a 3 1 2 11 3 9
per y b 680 130 550 2980 680 2290
Subcutaneous substitution c            
Maintain current volume (per d) 3 1 2 4 3 1
Newly available capacity (per d) 8
All available time for SQ 15 0 15 8 0 8
One additional first infusion, rest SQ 6 1 5 7 5 2
Newly available capacity (per y) b            
All available time for SQ 4030 0 4030 2020 0 2020
One additional first infusion, rest SQ 1550 260 1290 2020 1370 650
Rapid second infusion substitution            
Maintain current volume (per d) 3 1 2 6 3 3
Newly available capacity (per d) 6
All available time for second infusion 4 0 4 6 0 6
One additional first infusion 1 1 0 5 5 0
Newly available capacity (per y) b            
All available time for second infusion 980 0 980 1460 0 1460
One additional first infusion 260 260 0 1370 1370 0

Abbreviation: SQ; subcutaneous; Tx, treatment.

a

Number of infusions per day based on infusion center scheduling over a 3‐month period and hours of infusions based on time‐driven activity‐based costing estimates.

b

Based on the infusion center being open for 261 d/y.

c

Oncology pricing, with the 30‐minute visit reserved for SQ injection, based on the oncology practice assumed.